H.R. 8005 — Stop Pills That Kill Act

This section expands regulation of tableting and encapsulating machines under the Controlled Substances Act to cover their critical parts, including upper punches, lower punches, and dies. It requires records and reports for all regulated transactions involving these machines and parts, mandates permanent serial numbers, and prohibits removal or alteration of such numbers. The Attorney General must issue implementing regulations within 180 days of enactment, with the new requirements applying to machines manufactured after the regulations take effect and to pre-existing machines beginning 180 days after enactment.

This section prohibits any person from manufacturing or distributing a tableting machine, encapsulating machine, or critical part outside the United States if they intend or know it will be used to illicitly manufacture a controlled substance or listed chemical and will be unlawfully imported into the United States. It applies the same extraterritorial jurisdiction that covers controlled substances. It sets maximum prison terms of 8 years (15 years if more than 100 machines or 1,000 kilograms of chemicals are involved) and directs the Sentencing Commission to amend guidelines accordingly.

This section defines a “counterfeit pill containing an illicit synthetic substance” as a counterfeit substance under 21 U.S.C. 802(7) that contains fentanyl, a fentanyl analogue or related substance, methamphetamine, or other specified illicit drugs. It expands the prohibited acts in 21 U.S.C. 843(d)(2) to cover fentanyl, analogues, and fentanyl-related substances in addition to methamphetamine. It directs the DEA Administrator to establish and implement an operation and response plan within 180 days covering investigation, seizure, education, and prevention efforts, and requires the Attorney General to submit annual reports to Congress through FY2031 detailing seizures, markings, substances, geographic data, charges, convictions, and prevention measures.